Skip to main content

Take our TMF Risk Score Survey today!

Trial Interactive News & Press

Wednesday, September 26, 2018 | 12:56 PM

TransPerfect Announces Integration of ARender

NEW YORK & PARIS, September 26, 2018 TransPerfect Life Sciences, a leading provider of services and technologies to support global product development for the life sciences industry, today announced a strategic partnership with Arondor.

The partnership enables the integration of ARender—a high-speed streaming, viewing, and annotation software—into Trial Interactive, TransPerfect’s cloud-based e-clinical technology. The addition of ARender offers significant benefits to Trial Interactive users by placing key viewing and annotation functionality at the fingertips of study teams.

Some of ARender’s key features include:          

  •     Thin client viewing and annotation of 300+ document formats
  •     Compatibility with all browsers and devices
  •     Automatic document comparison capabilities
  •     Ability to create documents from one or many images

Michael Smyth, Division President of TransPerfect Life Sciences stated, “After evaluating and testing many options, ARender was the clear best choice to integrate with Trial Interactive: simple to deploy and use, fast renditions of complex documents, easy navigation, and the ability to compare documents—all which will save our TI users valuable time.”

“Arondor is excited to partner with TransPerfect, and we look forward to a mutually beneficial relationship. Our commitment is to truly be the ‘silver bullet’ for Trial Interactive document viewing, and we look forward to working with the TransPerfect team to deliver the best possible user experience for TI,” commented Alain Le Bras, CEO of Arondor.

Demos for Trial Interactive 9.2 with ARender can be scheduled by emailing

About Arondor

Arondor is an IT company created in 2002 by specialists in document management. Arondor proposes business solutions covering the entire document lifecycle. The company is headquartered in Paris, France with a team of 140 employees (including 115 consultants). Arondor provides all services from designing upstream requirements to application development and project implementation. In 2010 Arondor was requested by large customers to develop unique software solutions for applications that were not being effectively served by competition. As a result Arondor developed its own solutions: ARender (HTML5 viewer), Fast2 (an ETL tool), and Flower (an information and management tool). Please visit our website at

About Trial Interactive

TransPerfect’s Trial Interactive solution provides a collaborative, web-based platform for clinical development that enables sponsors, CROs, IRBs, and other vendors to maintain and update clinical trial documentation in a secure online environment, adhering to global regulatory requirements. With fully searchable solutions including investigator portals, Trial Interactive streamlines study timelines and reduces the administrative burdens of global clinical trials. As part of TransPerfect’s Life Sciences division, Trial Interactive is dedicated to working with clients on a global, collaborative level, supporting a wide range of requirements including e-feasibility, study start-up, eTMF review/reconciliation, mobile applications, learning management and document management systems, investigator portals, pharmacovigilance and safety management, and endpoint adjudication. For more information on Trial Interactive, please contact or +1 212.400.8848, or visit

About TransPerfect

TransPerfect is the world’s largest provider of language services and technology solutions for global business. From offices in over 90 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. More than 4,000 global organizations employ TransPerfect’s GlobalLink® Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at

Back to News